{"filing":{"accession_number":"0001493152-26-024353","cik":"0000946644","ticker":"AIM","company_name":"AIM ImmunoTech Inc.","form":"8-K","filing_date":"2026-05-19","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315226024353/form8-k.htm"},"events":[{"id":10180,"run_id":8926,"accession_number":"0001493152-26-024353","anchor_item_number":null,"event_type":"covenant_breach","event_domain":"financial","is_material":true,"confidence":0.65,"summary":"The filing discloses Amendment #2 to a Promissory Note with Streeterville Capital, LLC, extending the maturity date from June 30, 2026 to June 30, 2027 and adding a $10,000 extension fee. While the amendment itself is a negotiated modification rather than a breach, the need for a second extension of a debt obligation within approximately 16 months signals financial stress and inability to repay on the original schedule. The outstanding balance of $1,682,676.16 and repeated extensions suggest the company is managing liquidity constraints, which is material to investors assessing solvency risk.","company_name":"AIM ImmunoTech Inc.","ticker":"AIM","filing_date":"2026-05-19","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":297,"accession_number":"0001493152-26-024353","item_number":null,"item_title":null,"event_type":"covenant_breach","event_domain":"financial","is_material":true,"confidence":0.65,"reasoning":"The filing discloses Amendment #2 to a Promissory Note with Streeterville Capital, LLC, extending the maturity date from June 30, 2026 to June 30, 2027 and adding a $10,000 extension fee. While the amendment itself is a negotiated modification rather than a breach, the need for a second extension of a debt obligation within approximately 16 months signals financial stress and inability to repay on the original schedule. The outstanding balance of $1,682,676.16 and repeated extensions suggest the company is managing liquidity constraints, which is material to investors assessing solvency risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:41:46.700672+00:00","company_name":"AIM ImmunoTech Inc.","ticker":"AIM","filing_date":"2026-05-19"}]}